Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01286987
Title Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioMarin Pharmaceutical

pancreatic cancer

lung small cell carcinoma

Ewing sarcoma

ovarian cancer

prostate cancer

Advanced Solid Tumor

breast cancer



Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.